January 17, 2019
Earlier today, Johnson & Johnson announced plans for a multi-year research program it will be launching with Apple to explore the role Apple Watches could play in senior health monitoring.
Set to kickoff later this year, the pragmatic randomized controlled trial study will be conducted in the US and enroll adults aged 65 years or older, according to a statement. Specifically, the primary...
December 7, 2018
When Mango Health announced last month that CEO Jason Oberfest was stepping down, the company didn't mention where Oberfest was going. Now, according to his LinkedIn, first spotted by CNBC, he has joined Apple's health team in an unspecified role.
Mango Health, which launched in 2012, has achieved success, or at least longetivity, as a gameified, incentive-based medication adherence app. He's...
December 5, 2018
Smart pill bottle cap maker Pillsy has launched a subsidiary that will pair the adherence technology with a nutritional supplement subscription service.
Called Stride Nutrition, the service is now available for consumers in the US with plans to expand internationally in 2019.
At launch, Stride’s service will have consumers sign up for one of three different supplement combinations: a multivitamin...
December 4, 2018
Pillo, the countertop device that uses conversational artificial intelligence to help patients manage their treatments, is now available to consumers for online purchase, manufacturer Pillo Health announced this morning. The device is currently being sold for $499 alongside a one-year subscription to the company’s connected service.
Designed for older patients or those with chronic diseases and...
November 1, 2018
Chronic disease management startup Livongo announced a handful of new offerings and partnerships this week, all organized around the theme of “Applied Health Signals,” a framework for thinking about the technologies and capabilities Livongo offers.
“Health Signals is really an enabling technology,” Amar Kendale, Livongo’s chief product officer, told MobiHealthNews. “Something that is part of all...
November 1, 2018
AdhereTech, a seven-year-old digital health startup focused on smart pill bottles and medication adherence, has raised a round of growth equity funding, its first since 2014. The company didn’t disclose the amount of the investment, which came from New York-based Argentum.
The company has deals with six top 30 pharma companies and all the major specialty pharmas, CEO Josh Stein told...
October 16, 2018
Hero — a medication adherence system consisting of a countertop device, refill service, and connected app — has launched today to consumers on the back of $12 million in Series A funding.
The three-pillar platform is built for patients as well as their caregivers, and looks to reduce the stress and difficulty that each side faces when daily drug regimens begin to escalate, Kal Vepuri, founder and...
October 10, 2018
Children’s Health, a Texas-based pediatric health system, is teaming up with Proteus to pilot a new program aimed at tackling adherence issues in pediatric heart transplant patients by inserting ingestible sensors into prescribed pills, which can track when the medication was taken.
The system is made up of a wearable patch worn by the patient and the sensor-infused pill. When the pill is broken...
August 29, 2018
Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing. Rethink Impact was the lead investor, and was joined by Social Capital and other unnamed backers.
“We are incredibly excited to invest in Sempre Health as it uses its core technology to tackle the nearly $300...
August 27, 2018
A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.
The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...